A growing collection.
Always here to read.
Explore every article we have published, from the latest edition to earlier discoveries. Search a subject, choose a topic or revisit a particular month.
Cancer Treatment
6 articles · Newest source date first
observational (population registry analysis)WHO publishes first country-comparable childhood cancer survival estimates
WHO releases a global dataset with comparable five‑year survival estimates for childhood and adolescent lymphoid leukaemia across 194 countries, highlighting large survival gaps between regions and age groups.
Read article →
Ensartinib gains a positive European opinion for ALK-positive lung cancer
The targeted medicine is intended for selected adults with advanced non-small cell lung cancer.
Read article →
Phase III topline resultEnhertu meets Phase III PFS endpoint as first-line therapy for HER2-mutant advanced lung cancer
DESTINY-Lung04 met its primary progression-free survival endpoint versus platinum-pemetrexed chemotherapy plus pembrolizumab in previously untreated HER2-mutant advanced NSCLC.
Read article →
New iberdomide combination receives accelerated approval for previously treated multiple myeloma
The FDA has added a new oral CELMoD-based combination after a large randomized trial showed substantially deeper MRD-negative responses.
Read article →
FDA accelerated approvalOncolytic viral therapy plus nivolumab approved for advanced melanoma after PD-1 treatment
A genetically modified virus is now part of an FDA-approved immunotherapy strategy for a defined group of advanced melanoma patients.
Read article →
Phase 1 · 324 patientsFirst-in-class FcRH5×CD3 bispecific antibody shows activity in heavily pretreated myeloma
A fixed-duration cevostamab programme produced responses in a difficult late-line multiple myeloma population.
Read article →